Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

GelTex reports preliminary phase IIc results for RenaGel

April 10, 1997

Urologix's PMA for T3 System accepted for review

April 7, 1997

Hokuriku discloses agents for urinary incontinence

April 2, 1997

Anaritide and acute renal failure

April 1, 1997

Cheung Laboratories initiates preclinicals of BPH treatment system

March 27, 1997

Pharmacia & Upjohn seeks FDA approval for incontinence drug

March 27, 1997

Alpha-adrenoceptor blockers from SKB

March 27, 1997

Pharmacia & Upjohn prepares stereoisomers of FCE-28260

March 24, 1997

BBI Pharmaceuticals to fund phase I trial with soybean extract in BPH

March 14, 1997

Positive phase III results for GelTex's RenaGel

March 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...